Search bioRxivSearch

Biology subjects

Nowak, S.

Publications and source records attributed to Nowak, S..

2 recordsLinked to original sources

Modification and de novo design of non-ribosomal peptide synthetases (NRPS) using specific assembly points within condensation domains

Many important natural products are produced by non-ribosomal peptide synthetases (NRPSs) 1.These giant enzyme machines activate amino acids in an assembly line fashion in which a set of catalytically active domains is responsible for the section, activation, covalent binding and connection of a specific amino acid to the growing peptide chain 1,2. Since NRPS are not restricted to the incorporation of the 20 proteinogenic amino acids, their efficient manipulation would give access to a diverse range of peptides available biotechnologically. Here we describe a new fusion point inside condensation (C) domains of NRPSs that enables the efficient production of peptides, even containing non-natural amino acids, in yields higher than 280 mg/L. The technology called eXchange Unit 2.0 (XU2.0) also allows the generation of targeted peptide libraries and therefore might be suitable for the future identification of bioactive peptide derivatives for pharmaceutical and other applications.

synthetic biology

Superposition of survival curves as a tool for epistasis analysis of longevity interventions

A long-standing problem in ageing research is to understand how different factors contributing to longevity should be expected to act in combination under the assumption that they are independent. Standard epistasis analysis compares the extension of mean lifespan achieved by a combination of interventions to the prediction under an additive or multiplicative null model, but neither model is fundamentally justified. Moreover, the target of longevity interventions is not mean life span but the entire survival curve. Here we formulate superposition principles that predict the survival curve resulting from a combination of two interventions based on the survival curves of the individual treatments, and quantify epistasis as the deviation from this prediction. We test the method on a published data set comprising survival curves for all combinations of 4 different longevity interventions in Caenorhabditis elegans. We find that epistasis is generally weak even when the standard analysis indicates otherwise.

genetics